29 results
424B5
ITCI
Intra-Cellular Therapies Inc
5 Jan 22
Prospectus supplement for primary offering
4:51pm
will not generate sufficient revenues to achieve profitability.
The failure to attract and retain skilled personnel and key relationships could impair … and marketing personnel. There is currently intense competition for skilled executives and employees with relevant clinical development, scientific
424B5
ITCI
Intra-Cellular Therapies Inc
3 Jan 22
Prospectus supplement for primary offering
5:30pm
revenues to achieve profitability.
The failure to attract and retain skilled personnel and key relationships could impair our drug development … . There is currently
intense competition for skilled executives and employees with relevant clinical development, scientific, technical and sales
424B5
qhe3eymuug4q23j7
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
r7fs60 9rr48qq
9 Sep 20
Prospectus supplement for primary offering
4:40pm
424B5
g6xak
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
juu xpthrr2
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
wza lxa1l3gs3ro
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
9adktmpjhg wdxusa9l0
6 Jan 20
Automatic shelf registration
4:02pm
424B5
hyf7sc32csr1hzx6egrj
6 Mar 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.3
izunsnic
4 Mar 15
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
424B5
j6ep0 hvckrnsn8599
4 Mar 15
Prospectus supplement for primary offering
12:00am